Drammen Sykehus — Clinical Trial Site

18 Registered trials

8 Currently recruiting

Organisation

Drammen Sykehus

Location

Drammen, Norway

Identifier

ORG-100041790

Address

Dronninggata 28, 3004, Norway

Departments

4407: Forsknings avdelingen
5900: Department of Neurology
Cardiology
Department of Neurology
Department of Oncology
Indremedisinsk avdelning
Infectious Diseases
Medisinsk avdeling kardiologi
N/A
Onkologisk poliklinikk
Øre-nese-hals avdeling
Rheumatology
s

Clinical trials at this site (18)

Search interface

The Treat-JIA trial Pending

2026-525611-13-00 Juvenil Idiopatic Arthritis 6
Clinical trial that compares MK-2870 with or without pembrolizumab to chemotherapy in people with breast cancer that cannot be surgically re… Recruiting

2023-504918-29-00 Hormone receptor positive breast cancer 5 2024-08-22
Phase 3, Open-label Study of ARV-471 (PF-07850327) vs Fulvestrant in Participants With ER(+)/ HER2(-) Advanced Breast Cancer (VERITAC-2) Recruiting

2022-500544-38-00 Advanced Breast Cancer 5 2023-06-05
Antiplatelet therapy added to standard thromboprophylaxis to prevent thrombosis in pancreatic cancer patients - a randomized clinical trial … Recruiting

2023-509022-22-00 Pancreatic ductal cancer 5 2025-08-21
Thrombolysis in Factor Xa-inhibitors Trial (SIFT) Recruiting

2023-509907-34-01 acute ischemic stroke 5 2025-03-10
Clinical trial of MK-2870 in combination with pembrolizumab in people who have had surgery to treat triple negative breast cancer Recruiting

2023-504962-52-00 Triple negative breast cancer. 5 2024-07-10
Anticoagulation for Stroke Prevention In patients with Recent Episodes of Atrial Fibrillation occurring transiently with stress Recruiting

2023-509142-35-00 Atrial fibrillation after stress (e.g., noncardiac surg 6 2024-01-29
SACK Recruiting

2022-501600-10-00 Atrial fibrillation and Chronic Kidney Disease stage 5 5 2023-02-07
Efficacy of Hyperbaric oxygen in addition to standard treatment for acute sudden deafness Recruiting

2024-510798-84-00 Idiopathic sudden sensorineural hearing loss (ISSNHL) 10 2022-01-28
Weight loss in people living with overweight or obesity following treatment with cagrilintide Ended

2024-519530-24-00 Overweight and obesity 5 2025-10-31
Effect of proactive therapeutic drug monitoring on maintenance of sustained disease control in adults with rheumatoid arthritis on a subcuta… Ended

2023-510184-35-00 Rheumatoid arthritis 6 2024-08-20
A research study to find out whether a medicine called inclisiran helps to prevent cardiovascular death, heart attacks or strokes in people … Ended

2024-510735-21-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2021-11-26
An open-label extension study evaluating long-term safety, tolerability and effectiveness of ofatumumab in subjects with RMS Ended

2023-507906-15-00 Relapsing multiple sclerosis (RMS) 5 2019-01-30
The TAF-MS study Ended

2023-503814-62-00 Multiple sclerosis 4 2024-02-06
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis… Ended

2023-503794-38-00 Prevention of stroke or systemic embolism in atrial fib 5 2022-11-24
Efficacy and Safety of AXL-Inhibitor bemcentinib for the Treatment of Moderate COVID-19 (AXL-SolidAct) Ended

2022-500363-12-00 SARS CoV-2 (COVID-19) 4 2022-08-24
Cohort study of human mpox virus disease Ended

2022-501132-42-00 Monkeypox virus disease 6 2022-08-02
European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial (SolidAct) Ended

2022-500385-99-00 SARS-CoV II infection (Coronavirus disease) 5 2021-06-03